| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tonsillectomy | 9 | 2024 | 268 | 2.780 |
Why?
|
| Otolaryngology | 11 | 2021 | 685 | 2.330 |
Why?
|
| Angiofibroma | 5 | 2023 | 55 | 2.090 |
Why?
|
| Sinusitis | 15 | 2020 | 990 | 1.810 |
Why?
|
| Nasopharyngeal Neoplasms | 5 | 2023 | 286 | 1.780 |
Why?
|
| Palatine Tonsil | 5 | 2018 | 193 | 1.760 |
Why?
|
| Neck | 8 | 2021 | 731 | 1.600 |
Why?
|
| Tongue Diseases | 3 | 2023 | 68 | 1.320 |
Why?
|
| Endoscopy | 15 | 2020 | 1834 | 1.220 |
Why?
|
| Tonsillar Neoplasms | 2 | 2018 | 50 | 1.190 |
Why?
|
| Rhinitis | 9 | 2019 | 746 | 1.180 |
Why?
|
| Parotid Diseases | 2 | 2024 | 49 | 0.970 |
Why?
|
| Orbital Diseases | 4 | 2020 | 178 | 0.950 |
Why?
|
| Abscess | 6 | 2020 | 605 | 0.920 |
Why?
|
| Oral Ulcer | 1 | 2023 | 96 | 0.850 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 8 | 2021 | 323 | 0.810 |
Why?
|
| Thyroglossal Cyst | 5 | 2021 | 31 | 0.790 |
Why?
|
| Nasal Mucosa | 3 | 2016 | 412 | 0.760 |
Why?
|
| Head and Neck Neoplasms | 12 | 2019 | 2882 | 0.720 |
Why?
|
| Hypertrophy | 4 | 2018 | 555 | 0.700 |
Why?
|
| Child | 85 | 2024 | 79818 | 0.700 |
Why?
|
| Maxillary Sinus | 2 | 2020 | 180 | 0.690 |
Why?
|
| Pediatrics | 5 | 2018 | 3587 | 0.690 |
Why?
|
| Middle Ear Ventilation | 7 | 2018 | 99 | 0.650 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 265 | 0.620 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2018 | 19 | 0.610 |
Why?
|
| Odontogenic Cysts | 4 | 2000 | 42 | 0.600 |
Why?
|
| Granular Cell Tumor | 1 | 2017 | 48 | 0.550 |
Why?
|
| After-Hours Care | 1 | 2017 | 102 | 0.540 |
Why?
|
| Teratoma | 2 | 2017 | 403 | 0.540 |
Why?
|
| Nasal Polyps | 2 | 2020 | 395 | 0.530 |
Why?
|
| Nasal Obstruction | 4 | 2012 | 159 | 0.530 |
Why?
|
| Ciliary Motility Disorders | 1 | 2016 | 51 | 0.530 |
Why?
|
| Adenoidectomy | 6 | 2020 | 164 | 0.520 |
Why?
|
| Ibuprofen | 1 | 2017 | 229 | 0.520 |
Why?
|
| Vascular Malformations | 2 | 2021 | 464 | 0.510 |
Why?
|
| Burkitt Lymphoma | 1 | 2018 | 333 | 0.510 |
Why?
|
| Wnt Proteins | 1 | 2019 | 719 | 0.490 |
Why?
|
| Pain, Postoperative | 2 | 2024 | 1721 | 0.490 |
Why?
|
| Head | 1 | 2021 | 921 | 0.490 |
Why?
|
| Laryngeal Neoplasms | 2 | 2017 | 514 | 0.480 |
Why?
|
| Laryngoscopy | 4 | 2018 | 705 | 0.480 |
Why?
|
| Dacryocystorhinostomy | 4 | 2006 | 78 | 0.470 |
Why?
|
| Dysphonia | 1 | 2017 | 144 | 0.470 |
Why?
|
| Telephone | 1 | 2017 | 625 | 0.450 |
Why?
|
| Ear Neoplasms | 3 | 2010 | 118 | 0.450 |
Why?
|
| Skull Neoplasms | 2 | 2012 | 173 | 0.440 |
Why?
|
| Hemangioma | 3 | 2015 | 727 | 0.440 |
Why?
|
| Postoperative Complications | 9 | 2023 | 15637 | 0.420 |
Why?
|
| Otorhinolaryngologic Diseases | 3 | 2018 | 95 | 0.420 |
Why?
|
| Child, Preschool | 46 | 2021 | 42062 | 0.420 |
Why?
|
| Diagnosis, Differential | 16 | 2024 | 12951 | 0.410 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 2359 | 0.410 |
Why?
|
| Paranasal Sinus Diseases | 2 | 2011 | 121 | 0.400 |
Why?
|
| Bronchi | 1 | 2016 | 848 | 0.400 |
Why?
|
| Deglutition Disorders | 1 | 2018 | 625 | 0.400 |
Why?
|
| Turbinates | 1 | 2012 | 64 | 0.380 |
Why?
|
| Adolescent | 52 | 2023 | 87892 | 0.380 |
Why?
|
| Hearing Loss | 2 | 2018 | 780 | 0.380 |
Why?
|
| Catheterization | 2 | 2019 | 1426 | 0.380 |
Why?
|
| Hearing Disorders | 1 | 2011 | 126 | 0.380 |
Why?
|
| Mandibular Neoplasms | 1 | 2012 | 130 | 0.370 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2013 | 345 | 0.360 |
Why?
|
| Connexins | 2 | 2013 | 351 | 0.360 |
Why?
|
| Pilomatrixoma | 1 | 2010 | 24 | 0.360 |
Why?
|
| Humans | 131 | 2024 | 758406 | 0.350 |
Why?
|
| Trachea | 1 | 2016 | 1081 | 0.350 |
Why?
|
| Biopsy | 4 | 2016 | 6768 | 0.350 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2010 | 72 | 0.350 |
Why?
|
| Infant | 38 | 2021 | 36055 | 0.340 |
Why?
|
| Ear, External | 1 | 2010 | 164 | 0.340 |
Why?
|
| Facial Nerve Diseases | 1 | 2010 | 49 | 0.340 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2019 | 304 | 0.340 |
Why?
|
| Ludwig's Angina | 1 | 2009 | 6 | 0.340 |
Why?
|
| Vocal Cord Paralysis | 3 | 2009 | 272 | 0.330 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2010 | 134 | 0.320 |
Why?
|
| Family Practice | 1 | 2011 | 510 | 0.310 |
Why?
|
| Pharyngeal Diseases | 3 | 2007 | 134 | 0.310 |
Why?
|
| Otitis Media with Effusion | 4 | 2014 | 114 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 3480 | 0.300 |
Why?
|
| Laryngeal Muscles | 1 | 2009 | 107 | 0.300 |
Why?
|
| Patient Preference | 1 | 2015 | 921 | 0.300 |
Why?
|
| Nasolacrimal Duct | 2 | 2006 | 79 | 0.300 |
Why?
|
| Choristoma | 2 | 2007 | 207 | 0.290 |
Why?
|
| Adenoids | 2 | 2006 | 35 | 0.290 |
Why?
|
| Maxillary Diseases | 2 | 1998 | 48 | 0.290 |
Why?
|
| Retrospective Studies | 38 | 2023 | 80168 | 0.290 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 1373 | 0.290 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2009 | 143 | 0.290 |
Why?
|
| Male | 84 | 2024 | 358747 | 0.280 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2007 | 58 | 0.280 |
Why?
|
| Hodgkin Disease | 1 | 2015 | 1377 | 0.280 |
Why?
|
| Point Mutation | 2 | 2013 | 1593 | 0.280 |
Why?
|
| Nasal Cavity | 2 | 2007 | 304 | 0.280 |
Why?
|
| Siblings | 1 | 2010 | 824 | 0.270 |
Why?
|
| Mouth Neoplasms | 1 | 2012 | 593 | 0.270 |
Why?
|
| Mandibular Diseases | 2 | 1998 | 119 | 0.270 |
Why?
|
| Electrocoagulation | 2 | 2006 | 152 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 25 | 2015 | 20500 | 0.260 |
Why?
|
| Genetic Testing | 1 | 2019 | 3530 | 0.260 |
Why?
|
| Specialties, Surgical | 1 | 2011 | 388 | 0.260 |
Why?
|
| Acute Disease | 15 | 2020 | 7225 | 0.260 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 2005 | 21 | 0.260 |
Why?
|
| Tongue | 2 | 2023 | 404 | 0.260 |
Why?
|
| Radiographic Image Enhancement | 1 | 2010 | 875 | 0.250 |
Why?
|
| Cysts | 1 | 2010 | 681 | 0.250 |
Why?
|
| Nose Neoplasms | 1 | 2007 | 249 | 0.250 |
Why?
|
| Otitis Media | 8 | 2000 | 285 | 0.250 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 3364 | 0.240 |
Why?
|
| Catheter Ablation | 3 | 2016 | 2740 | 0.240 |
Why?
|
| Bronchogenic Cyst | 1 | 2004 | 28 | 0.240 |
Why?
|
| Muscle Neoplasms | 1 | 2005 | 133 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2018 | 36284 | 0.230 |
Why?
|
| Drainage | 3 | 2020 | 1161 | 0.230 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 694 | 0.230 |
Why?
|
| Tongue Neoplasms | 1 | 2005 | 183 | 0.230 |
Why?
|
| Parotid Gland | 1 | 2024 | 175 | 0.220 |
Why?
|
| Neuroblastoma | 1 | 2012 | 1251 | 0.220 |
Why?
|
| Female | 74 | 2024 | 390323 | 0.220 |
Why?
|
| Lymphoma, Follicular | 1 | 2007 | 453 | 0.220 |
Why?
|
| Internship and Residency | 5 | 2017 | 5865 | 0.220 |
Why?
|
| Orbital Pseudotumor | 1 | 2003 | 42 | 0.210 |
Why?
|
| Thyroidectomy | 1 | 2009 | 902 | 0.210 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2007 | 533 | 0.210 |
Why?
|
| Myxoma | 1 | 2023 | 114 | 0.210 |
Why?
|
| Monitoring, Intraoperative | 2 | 2009 | 939 | 0.210 |
Why?
|
| Airway Obstruction | 4 | 1993 | 661 | 0.210 |
Why?
|
| Clinical Competence | 4 | 2016 | 4775 | 0.210 |
Why?
|
| Thyroid Gland | 2 | 2007 | 1168 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2018 | 3418 | 0.200 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2023 | 125 | 0.200 |
Why?
|
| Chronic Disease | 11 | 2019 | 9267 | 0.200 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2023 | 218 | 0.190 |
Why?
|
| Parents | 1 | 2015 | 3548 | 0.190 |
Why?
|
| Branchial Region | 3 | 2010 | 35 | 0.190 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 1406 | 0.190 |
Why?
|
| Emergency Service, Hospital | 5 | 2023 | 7810 | 0.180 |
Why?
|
| Lymphangioma, Cystic | 2 | 2010 | 34 | 0.180 |
Why?
|
| Meningocele | 1 | 2000 | 46 | 0.180 |
Why?
|
| Edema | 1 | 2024 | 768 | 0.180 |
Why?
|
| Nasal Decongestants | 1 | 2020 | 29 | 0.180 |
Why?
|
| Recurrence | 7 | 2020 | 8426 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 7403 | 0.170 |
Why?
|
| Ear Canal | 2 | 1998 | 146 | 0.170 |
Why?
|
| Glucocorticoids | 1 | 2009 | 2144 | 0.170 |
Why?
|
| Periosteum | 1 | 2020 | 138 | 0.170 |
Why?
|
| Bronchoscopes | 1 | 1999 | 64 | 0.160 |
Why?
|
| Tomography, X-Ray | 1 | 2018 | 60 | 0.160 |
Why?
|
| Phenylephrine | 1 | 1999 | 293 | 0.160 |
Why?
|
| History, 20th Century | 2 | 2021 | 2772 | 0.160 |
Why?
|
| Keratins | 1 | 2000 | 497 | 0.160 |
Why?
|
| Calcinosis | 1 | 2007 | 1467 | 0.160 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 89 | 0.160 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2018 | 75 | 0.150 |
Why?
|
| Eustachian Tube | 3 | 2014 | 96 | 0.150 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2019 | 119 | 0.150 |
Why?
|
| Physician Assistants | 1 | 2019 | 188 | 0.140 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 1989 | 169 | 0.140 |
Why?
|
| Professional Role | 1 | 2019 | 309 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 8945 | 0.140 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2015 | 1110 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 268 | 0.140 |
Why?
|
| Educational Measurement | 2 | 2016 | 1248 | 0.130 |
Why?
|
| Socioeconomic Factors | 5 | 2017 | 7818 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7378 | 0.130 |
Why?
|
| Ethmoid Sinusitis | 1 | 1995 | 25 | 0.130 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11070 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 651 | 0.130 |
Why?
|
| Tracheitis | 2 | 1994 | 29 | 0.130 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2021 | 465 | 0.130 |
Why?
|
| Brain Abscess | 2 | 2013 | 120 | 0.130 |
Why?
|
| Tracheal Stenosis | 1 | 1998 | 226 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2000 | 560 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2009 | 2332 | 0.120 |
Why?
|
| Health Status Indicators | 1 | 2000 | 970 | 0.120 |
Why?
|
| Dacryocystitis | 1 | 1995 | 68 | 0.120 |
Why?
|
| Steroids | 1 | 2020 | 926 | 0.120 |
Why?
|
| Foreign Bodies | 2 | 1998 | 397 | 0.120 |
Why?
|
| Ultrasonography | 3 | 2018 | 5952 | 0.120 |
Why?
|
| Combined Modality Therapy | 5 | 2012 | 8530 | 0.120 |
Why?
|
| Hospitals, Pediatric | 3 | 2019 | 1854 | 0.120 |
Why?
|
| Ambulatory Care | 2 | 2015 | 2768 | 0.110 |
Why?
|
| Drug Therapy, Combination | 5 | 2009 | 6293 | 0.110 |
Why?
|
| Lymph Nodes | 3 | 2015 | 3485 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 2 | 2015 | 358 | 0.110 |
Why?
|
| Insurance, Health | 2 | 2017 | 2495 | 0.110 |
Why?
|
| Consensus | 2 | 2020 | 3099 | 0.110 |
Why?
|
| Orbital Cellulitis | 1 | 2013 | 33 | 0.110 |
Why?
|
| Laryngeal Edema | 1 | 1993 | 21 | 0.110 |
Why?
|
| Granuloma, Foreign-Body | 1 | 1993 | 42 | 0.110 |
Why?
|
| United States | 11 | 2021 | 72136 | 0.110 |
Why?
|
| Branchioma | 2 | 1992 | 17 | 0.110 |
Why?
|
| Equipment Contamination | 1 | 2014 | 179 | 0.110 |
Why?
|
| Uvula | 1 | 1992 | 15 | 0.110 |
Why?
|
| Professional Competence | 1 | 2016 | 431 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 2557 | 0.100 |
Why?
|
| Follow-Up Studies | 10 | 2019 | 39059 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2013 | 200 | 0.100 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 441 | 0.100 |
Why?
|
| Rhinometry, Acoustic | 1 | 2012 | 8 | 0.100 |
Why?
|
| Mucociliary Clearance | 2 | 2013 | 80 | 0.100 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 442 | 0.100 |
Why?
|
| Bacteremia | 1 | 1999 | 980 | 0.100 |
Why?
|
| Laryngitis | 1 | 1992 | 27 | 0.100 |
Why?
|
| Young Adult | 8 | 2019 | 58808 | 0.100 |
Why?
|
| Infant, Newborn | 9 | 2018 | 26183 | 0.100 |
Why?
|
| Granuloma | 2 | 2005 | 327 | 0.100 |
Why?
|
| Pigmentation Disorders | 1 | 1992 | 105 | 0.100 |
Why?
|
| Nasal Septum | 1 | 2012 | 130 | 0.100 |
Why?
|
| Patient Readmission | 2 | 2023 | 3261 | 0.100 |
Why?
|
| Students | 1 | 2021 | 1734 | 0.090 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 3526 | 0.090 |
Why?
|
| Treatment Outcome | 11 | 2016 | 64378 | 0.090 |
Why?
|
| Boston | 3 | 2021 | 9304 | 0.090 |
Why?
|
| Apnea | 1 | 1992 | 195 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 5797 | 0.090 |
Why?
|
| Intubation, Intratracheal | 3 | 1997 | 1327 | 0.090 |
Why?
|
| Triage | 1 | 2017 | 986 | 0.090 |
Why?
|
| Incidence | 5 | 2018 | 21272 | 0.090 |
Why?
|
| Biopsy, Needle | 3 | 2015 | 1630 | 0.090 |
Why?
|
| Cross Infection | 1 | 1999 | 1432 | 0.090 |
Why?
|
| Hair Diseases | 1 | 2010 | 72 | 0.090 |
Why?
|
| Neoplasm Staging | 5 | 2018 | 11152 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 162 | 0.090 |
Why?
|
| Biofilms | 1 | 2014 | 621 | 0.080 |
Why?
|
| Embolization, Therapeutic | 2 | 2018 | 1407 | 0.080 |
Why?
|
| Temporal Bone | 3 | 2009 | 683 | 0.080 |
Why?
|
| Age Factors | 4 | 2015 | 18358 | 0.080 |
Why?
|
| Sheep | 1 | 2012 | 1441 | 0.080 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2009 | 50 | 0.080 |
Why?
|
| Basal Cell Nevus Syndrome | 2 | 2000 | 38 | 0.080 |
Why?
|
| Rhinoplasty | 1 | 2012 | 238 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2015 | 23884 | 0.080 |
Why?
|
| Adult | 22 | 2020 | 219935 | 0.070 |
Why?
|
| Hyoid Bone | 1 | 2007 | 38 | 0.070 |
Why?
|
| Laser Therapy | 2 | 2007 | 1089 | 0.070 |
Why?
|
| Hemorrhage | 2 | 2017 | 3400 | 0.070 |
Why?
|
| Insurance Coverage | 2 | 2017 | 1933 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 1852 | 0.070 |
Why?
|
| Microsurgery | 2 | 2011 | 796 | 0.070 |
Why?
|
| Prospective Studies | 11 | 2016 | 54137 | 0.070 |
Why?
|
| Nose Diseases | 1 | 2007 | 79 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1378 | 0.070 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 413 | 0.070 |
Why?
|
| Thyroid Function Tests | 1 | 2007 | 289 | 0.070 |
Why?
|
| Respiratory Sounds | 2 | 1993 | 697 | 0.070 |
Why?
|
| Papilloma | 1 | 2007 | 141 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 496 | 0.070 |
Why?
|
| Aneurysm | 1 | 1989 | 336 | 0.070 |
Why?
|
| Acidosis, Renal Tubular | 2 | 1998 | 50 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2019 | 7980 | 0.060 |
Why?
|
| Fibroma | 1 | 2007 | 190 | 0.060 |
Why?
|
| Ethambutol | 1 | 2005 | 59 | 0.060 |
Why?
|
| Urology | 1 | 2011 | 423 | 0.060 |
Why?
|
| Reoperation | 3 | 2006 | 4282 | 0.060 |
Why?
|
| Lymphoma, B-Cell | 1 | 1992 | 935 | 0.060 |
Why?
|
| Clarithromycin | 1 | 2005 | 85 | 0.060 |
Why?
|
| Maxilla | 3 | 1997 | 491 | 0.060 |
Why?
|
| Gadolinium | 1 | 2010 | 959 | 0.060 |
Why?
|
| Lymphoma | 2 | 1992 | 1896 | 0.060 |
Why?
|
| Emergency Treatment | 1 | 2009 | 496 | 0.060 |
Why?
|
| Surgery Department, Hospital | 1 | 2006 | 177 | 0.060 |
Why?
|
| Time Factors | 4 | 2018 | 39872 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6821 | 0.060 |
Why?
|
| Voice Quality | 1 | 2006 | 226 | 0.060 |
Why?
|
| Bone Diseases | 1 | 1988 | 419 | 0.060 |
Why?
|
| Neoplasms, Second Primary | 1 | 1992 | 1056 | 0.060 |
Why?
|
| Sex Factors | 2 | 2015 | 10504 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 1991 | 1184 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 4106 | 0.060 |
Why?
|
| Thyroxine | 1 | 2007 | 667 | 0.060 |
Why?
|
| Lymphatic Diseases | 1 | 2005 | 319 | 0.060 |
Why?
|
| Electromyography | 1 | 2009 | 1388 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2017 | 4652 | 0.060 |
Why?
|
| Prognosis | 4 | 2015 | 29557 | 0.050 |
Why?
|
| Rifampin | 1 | 2005 | 339 | 0.050 |
Why?
|
| Hospitalization | 1 | 2023 | 10652 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2010 | 1927 | 0.050 |
Why?
|
| Otitis | 1 | 2002 | 21 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3806 | 0.050 |
Why?
|
| Voice Disorders | 1 | 2006 | 286 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2023 | 180 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 1989 | 872 | 0.050 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 1995 | 110 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2007 | 522 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2013 | 8553 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3617 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10112 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2007 | 694 | 0.050 |
Why?
|
| Cross-Sectional Studies | 7 | 2017 | 25956 | 0.050 |
Why?
|
| Hematoma | 2 | 2019 | 768 | 0.050 |
Why?
|
| Necrosis | 1 | 2005 | 1604 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2005 | 586 | 0.050 |
Why?
|
| Ear, Middle | 3 | 2009 | 338 | 0.050 |
Why?
|
| Facial Paralysis | 2 | 1996 | 345 | 0.050 |
Why?
|
| Dentigerous Cyst | 1 | 2000 | 18 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1793 | 0.050 |
Why?
|
| Tympanic Membrane | 1 | 2002 | 232 | 0.050 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 5404 | 0.040 |
Why?
|
| Mediastinal Cyst | 2 | 1992 | 29 | 0.040 |
Why?
|
| Workload | 1 | 2006 | 847 | 0.040 |
Why?
|
| Ameloblastoma | 1 | 2000 | 42 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2008 | 2666 | 0.040 |
Why?
|
| Middle Aged | 7 | 2020 | 219568 | 0.040 |
Why?
|
| Jaw Neoplasms | 1 | 2000 | 70 | 0.040 |
Why?
|
| Polyps | 2 | 2009 | 197 | 0.040 |
Why?
|
| Cavernous Sinus | 1 | 2000 | 123 | 0.040 |
Why?
|
| General Surgery | 1 | 2011 | 1677 | 0.040 |
Why?
|
| Seroma | 1 | 2019 | 76 | 0.040 |
Why?
|
| Pterygopalatine Fossa | 1 | 2018 | 8 | 0.040 |
Why?
|
| Curriculum | 2 | 2011 | 3717 | 0.040 |
Why?
|
| Comorbidity | 1 | 2013 | 10495 | 0.040 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 1999 | 53 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2000 | 614 | 0.040 |
Why?
|
| Meningococcal Vaccines | 1 | 1999 | 94 | 0.040 |
Why?
|
| Income | 2 | 2019 | 1872 | 0.040 |
Why?
|
| Hearing Loss, Bilateral | 1 | 1998 | 53 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2011 | 3891 | 0.040 |
Why?
|
| Contrast Media | 1 | 2012 | 5298 | 0.040 |
Why?
|
| Optics and Photonics | 1 | 2000 | 304 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 1043 | 0.040 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2019 | 216 | 0.040 |
Why?
|
| Vestibular Aqueduct | 1 | 1998 | 73 | 0.040 |
Why?
|
| Dilatation | 1 | 2019 | 307 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 1999 | 328 | 0.040 |
Why?
|
| Skull Base | 1 | 2000 | 291 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 1705 | 0.040 |
Why?
|
| Fistula | 2 | 2009 | 214 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 401 | 0.040 |
Why?
|
| Massachusetts | 1 | 2010 | 8823 | 0.040 |
Why?
|
| Antiporters | 1 | 1998 | 278 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3671 | 0.030 |
Why?
|
| Quality of Life | 3 | 2006 | 13285 | 0.030 |
Why?
|
| Prevalence | 1 | 2013 | 15651 | 0.030 |
Why?
|
| Skin | 1 | 2010 | 4464 | 0.030 |
Why?
|
| Sick Role | 1 | 1997 | 230 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 553 | 0.030 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2009 | 45 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2000 | 1083 | 0.030 |
Why?
|
| Vestibular Diseases | 1 | 1998 | 229 | 0.030 |
Why?
|
| Random Allocation | 1 | 2000 | 2385 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2021 | 1812 | 0.030 |
Why?
|
| Ethmoid Sinus | 1 | 1995 | 57 | 0.030 |
Why?
|
| Facial Bones | 1 | 1997 | 205 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 168218 | 0.030 |
Why?
|
| Haemophilus Infections | 1 | 1995 | 94 | 0.030 |
Why?
|
| Mastoiditis | 1 | 1995 | 37 | 0.030 |
Why?
|
| Salivary Gland Diseases | 1 | 2015 | 37 | 0.030 |
Why?
|
| Haemophilus influenzae | 1 | 1995 | 180 | 0.030 |
Why?
|
| Retropharyngeal Abscess | 1 | 1994 | 21 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13591 | 0.030 |
Why?
|
| Mandible | 2 | 1997 | 750 | 0.030 |
Why?
|
| Epiglottitis | 1 | 1994 | 19 | 0.030 |
Why?
|
| Radio Waves | 1 | 2016 | 250 | 0.030 |
Why?
|
| Drug Combinations | 2 | 1991 | 2020 | 0.030 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 1067 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1999 | 642 | 0.030 |
Why?
|
| Frontal Sinusitis | 1 | 1993 | 19 | 0.030 |
Why?
|
| Judgment | 1 | 2016 | 273 | 0.030 |
Why?
|
| Laryngeal Diseases | 1 | 1997 | 243 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 1999 | 732 | 0.030 |
Why?
|
| Arteriovenous Malformations | 1 | 1997 | 397 | 0.030 |
Why?
|
| Polysomnography | 1 | 2020 | 1824 | 0.030 |
Why?
|
| Problem Solving | 1 | 2016 | 440 | 0.030 |
Why?
|
| Risk Factors | 3 | 2013 | 73809 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 1791 | 0.030 |
Why?
|
| Lacrimal Apparatus | 1 | 1995 | 223 | 0.030 |
Why?
|
| Parotid Neoplasms | 1 | 2015 | 157 | 0.030 |
Why?
|
| Patient Admission | 1 | 2021 | 1372 | 0.030 |
Why?
|
| Laryngismus | 1 | 1992 | 29 | 0.030 |
Why?
|
| Cerebellar Diseases | 1 | 1995 | 219 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 463 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18119 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2111 | 0.030 |
Why?
|
| Otitis Media, Suppurative | 1 | 1992 | 27 | 0.030 |
Why?
|
| Eye Infections, Bacterial | 1 | 1995 | 239 | 0.030 |
Why?
|
| Enterococcus faecalis | 1 | 1993 | 246 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 312 | 0.030 |
Why?
|
| Lymphangioma | 1 | 1992 | 61 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2014 | 567 | 0.020 |
Why?
|
| Algorithms | 2 | 2010 | 13961 | 0.020 |
Why?
|
| Medicaid | 2 | 2015 | 2807 | 0.020 |
Why?
|
| Polymyxin B | 1 | 1991 | 44 | 0.020 |
Why?
|
| Bacitracin | 1 | 1991 | 24 | 0.020 |
Why?
|
| Snoring | 1 | 1993 | 206 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 1993 | 218 | 0.020 |
Why?
|
| Dermoid Cyst | 1 | 1992 | 92 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4317 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2019 | 1192 | 0.020 |
Why?
|
| Neomycin | 1 | 1991 | 93 | 0.020 |
Why?
|
| Europe | 1 | 2018 | 3420 | 0.020 |
Why?
|
| Radiography | 2 | 1996 | 6954 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 1993 | 343 | 0.020 |
Why?
|
| Office Visits | 1 | 2015 | 596 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2015 | 394 | 0.020 |
Why?
|
| Mathematics | 1 | 1992 | 707 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2015 | 9650 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2010 | 41256 | 0.020 |
Why?
|
| Hypopharynx | 1 | 2010 | 53 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2016 | 789 | 0.020 |
Why?
|
| Sclerosing Solutions | 1 | 2010 | 79 | 0.020 |
Why?
|
| Otitis Externa | 1 | 1989 | 17 | 0.020 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2009 | 15 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 1997 | 1165 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2015 | 619 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 1992 | 367 | 0.020 |
Why?
|
| Bleomycin | 1 | 2010 | 495 | 0.020 |
Why?
|
| Ear Diseases | 1 | 1991 | 177 | 0.020 |
Why?
|
| Sclerotherapy | 1 | 2010 | 180 | 0.020 |
Why?
|
| Mastoid | 1 | 2009 | 98 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2010 | 172 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1991 | 247 | 0.020 |
Why?
|
| Blood | 1 | 1991 | 586 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1991 | 578 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 5331 | 0.020 |
Why?
|
| Hearing Loss, Conductive | 1 | 1989 | 159 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1993 | 601 | 0.020 |
Why?
|
| Labyrinth Diseases | 1 | 2009 | 151 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2015 | 2432 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2500 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2021 | 3433 | 0.020 |
Why?
|
| Semicircular Canals | 1 | 2009 | 203 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2513 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 432 | 0.020 |
Why?
|
| Health Surveys | 1 | 2017 | 4064 | 0.020 |
Why?
|
| Larynx | 1 | 1992 | 492 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6439 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 981 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1993 | 781 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1994 | 1401 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 29915 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 675 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 222 | 0.020 |
Why?
|
| Methods | 1 | 1986 | 1074 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2010 | 358 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 167768 | 0.020 |
Why?
|
| Child Development | 1 | 1997 | 2285 | 0.020 |
Why?
|
| Education, Medical | 1 | 1997 | 1725 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5199 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 1998 | 3586 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1989 | 939 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1993 | 973 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1177 | 0.010 |
Why?
|
| New York | 1 | 2006 | 874 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2112 | 0.010 |
Why?
|
| Angiography | 1 | 1989 | 1599 | 0.010 |
Why?
|
| Debridement | 1 | 2006 | 492 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9160 | 0.010 |
Why?
|
| Genes, Recessive | 2 | 1998 | 626 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 1547 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9273 | 0.010 |
Why?
|
| Health Expenditures | 1 | 2015 | 2347 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2010 | 1028 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1990 | 3991 | 0.010 |
Why?
|
| Physicians | 1 | 2000 | 4580 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 653 | 0.010 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2002 | 210 | 0.010 |
Why?
|
| Cellulitis | 2 | 1994 | 207 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12096 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1985 | 1680 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12721 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2850 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1992 | 1911 | 0.010 |
Why?
|
| Fatigue | 1 | 2006 | 1542 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2000 | 298 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1998 | 128 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1998 | 103 | 0.010 |
Why?
|
| Risk | 1 | 2010 | 9599 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.010 |
Why?
|
| Medical Errors | 1 | 2006 | 1255 | 0.010 |
Why?
|
| Medicare | 1 | 2015 | 6741 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1992 | 4217 | 0.010 |
Why?
|
| Halothane | 1 | 1997 | 200 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13468 | 0.010 |
Why?
|
| Anesthesia, Intravenous | 1 | 1997 | 130 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15225 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 1997 | 166 | 0.010 |
Why?
|
| Anesthesia, Inhalation | 1 | 1997 | 220 | 0.010 |
Why?
|
| Endoscopes | 1 | 1997 | 168 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2006 | 3527 | 0.010 |
Why?
|
| Pneumococcal Vaccines | 1 | 1999 | 397 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 1570 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1998 | 862 | 0.010 |
Why?
|
| Electrodiagnosis | 1 | 1996 | 148 | 0.010 |
Why?
|
| Laryngoscopes | 1 | 1997 | 146 | 0.010 |
Why?
|
| Anesthetics, Intravenous | 1 | 1997 | 396 | 0.010 |
Why?
|
| Cholesteatoma | 1 | 1993 | 28 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1468 | 0.010 |
Why?
|
| Fusobacterium necrophorum | 1 | 1992 | 14 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12262 | 0.010 |
Why?
|
| Fusobacterium Infections | 1 | 1992 | 53 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 1997 | 574 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1992 | 11709 | 0.010 |
Why?
|
| Clinical Clerkship | 1 | 1997 | 563 | 0.010 |
Why?
|
| Propofol | 1 | 1997 | 606 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1994 | 617 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 14490 | 0.010 |
Why?
|
| Acoustic Impedance Tests | 1 | 1988 | 110 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20055 | 0.000 |
Why?
|
| Sound | 1 | 1988 | 257 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1994 | 2249 | 0.000 |
Why?
|
| Forecasting | 1 | 1994 | 2923 | 0.000 |
Why?
|
| Hypertension | 1 | 1985 | 8499 | 0.000 |
Why?
|
| Pedigree | 1 | 1993 | 4578 | 0.000 |
Why?
|
| Pressure | 1 | 1988 | 1155 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 4919 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 14641 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1997 | 22029 | 0.000 |
Why?
|
| Logistic Models | 1 | 1993 | 13276 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 58683 | 0.000 |
Why?
|